Fig. 3From: Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancerKaplan-Meier curves for recurrence-free survival (RFS) of patients with estrogen-receptor-positive tumors based on radiological complete response (black line no enhancement) and those with residual enhancement (blue line) identified on magnetic resonance imaging after neoadjuvant chemotherapy. Log-rank test p = 0.012. Numbers of patients at risk in each group are shown above the x-axis Back to article page